Drugs / Ingovax ACWY
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03263403 | Aug 2017 → Mar 2018 | meningococcal infection | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ingovax ACWY | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03263403 ↗ |
| Route | Subcutaneous | “for subcutaneous use” NCT03263403 ↗ |